Skip to main content
Clinical Trials/NCT01816893
NCT01816893
Completed
Not Applicable

Hypoglycemia and Autonomic Nervous System Function

Brigham and Women's Hospital2 sites in 1 country22 target enrollmentStarted: June 8, 2004Last updated:
ConditionsHypoglycemia

Overview

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
2
Primary Endpoint
Change in Baroreflex Sensitivity

Overview

Brief Summary

The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Baroreflex Sensitivity

Time Frame: 16 hours after euglycemic and hypoglycemic clamps as compared to baseline

The change in baroreflex sensitivity (milliseconds/mm Hg) is calculated as baroreflex sensitivity (milliseconds/mm Hg) on day 3 \[assessed 16 hours after the clamp\] minus baroreflex sensitivity (milliseconds/mm Hg) on day 1 \[baseline assessment on the day prior to the clamp\]). Change in baroreflex sensitivity in euglycemic clamp arm is compared to change in baroreflex sensitivity in hypoglycemic arm.

Secondary Outcomes

  • Muscle Sympathetic Nerve Activity(16 hours after euglycemic and hypoglycemic clamps)
  • Catecholamine Response to Lower-body Negative Pressure(16 hours after euglycemic and hypoglycemic clamps)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gail Adler

Associate Professor of Medicine

Brigham and Women's Hospital

Study Sites (2)

Loading locations...

Similar Trials